News und Analysen
MannKind Q2 Earnings Call Highlights
Key Points
- Interested in MannKind Corporation? Here are five stocks we like better.
- Second-quarter revenue rose 43% to $109.4 million, driven by commercial products and collaboration revenue
Kontron Aktie: 12,6 Prozent Minus auf Wochensicht
Kontron hat am heutigen Donnerstag den Halbjahresfinanzbericht 2026 vorgelegt und die EBITDA-Prognose von 225…
Der Beitrag Kontron Aktie: 12,6 Prozent Minus auf Wochensicht erschien zuerst auf kapit
OHB: 3,35 Milliarden Euro Auftragsbestand
OHB SE legt heute die Zahlen zum ersten Halbjahr 2026 vor und erläutert sie…
Der Beitrag OHB: 3,35 Milliarden Euro Auftragsbestand erschien zuerst auf kapitalmarktexperten.de.
Quelle kapitalmarktexp
Inseego Q2 Earnings Call Highlights
Key Points
- Interested in Inseego? Here are five stocks we like better.
- Q2 revenue beat expectations: Inseego reported $44 million in revenue, up 28% sequentially and 9% year over year, helped
Honest Q2 Earnings Call Highlights
Key Points
- Interested in The Honest Company, Inc.? Here are five stocks we like better.
- Honest delivered strong underlying performance despite lower reported revenue: Q2 revenue fell 10.9% to
Almonty Aktie: 13,94 Prozent nach TSX-Rückzug
Fünf Wochen technischer Ausverkauf, dann die Wende: Almonty Industries hat den Rückzug von der…
Der Beitrag Almonty Aktie: 13,94 Prozent nach TSX-Rückzug erschien zuerst auf kapitalmarktexperten.de.
Energy Recovery Q2 Earnings Call Highlights
Key Points
- Interested in Energy Recovery, Inc.? Here are five stocks we like better.
- Middle East desalination growth remains delayed: Energy Recovery’s pipeline is strong and extends several
Evolus Q2 Earnings Call Highlights
Key Points
- Interested in Evolus, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Evolus reported 21% revenue growth to $84.1 million and its third consecutive
eBay Q2 Earnings Call Highlights
Key Points
- Interested in eBay Inc.? Here are five stocks we like better.
- eBay exceeded second-quarter expectations: Organic, FX-neutral GMV rose 14% to $22.4 billion, revenue increased 14% to
Dave Q2 Earnings Call Highlights
Key Points
- Interested in Dave Inc.? Here are five stocks we like better.
- Strong Q2 performance: Revenue rose 30% year over year to $171 million, while adjusted EBITDA increased 48% to $76
Cytek Biosciences Q2 Earnings Call Highlights
Key Points
- Interested in Cytek Biosciences, Inc.? Here are five stocks we like better.
- Revenue increased 6% year over year to $48.1 million, driven by 18% U.S. growth, strong China
Clearfield Q3 Earnings Call Highlights
Key Points
- Interested in Clearfield, Inc.? Here are five stocks we like better.
- Third-quarter sales rose 13% year over year to $43.9 million, while net income increased to $3 million, or $0.22
Coherus Oncology Q2 Earnings Call Highlights
Key Points
- Interested in Coherus Oncology, Inc.? Here are five stocks we like better.
- Clinical milestones are approaching: Coherus expects formal October data from its fully enrolled
Central Garden & Pet Q3 Earnings Call Highlights
Key Points
- Interested in Central Garden & Pet Company? Here are five stocks we like better.
- Central Garden & Pet raised its fiscal 2026 adjusted EPS outlook to $2.85 or better from $2.70
Netlist Lands Samsung Alliance Worth Up to $750M in Patent Fees
Key Points
- Interested in Netlist, Inc.? Here are five stocks we like better.
- Netlist and Samsung signed a five-year strategic alliance covering patent cross-licensing, memory supply
Blue Bird Q3 Earnings Call Highlights
Key Points
- Interested in Blue Bird Corporation? Here are five stocks we like better.
- Strong Q3 performance: Blue Bird reported $517 million in revenue and record adjusted EBITDA of $71
Barrett Business Services Q2 Earnings Call Highlights
Key Points
- Interested in Barrett Business Services, Inc.? Here are five stocks we like better.
- Q2 growth was modest: Gross billings rose 2.6% year over year to $2.29 billion, while diluted EPS
Amtech Systems Q3 Earnings Call Highlights
Key Points
- Interested in Amtech Systems, Inc.? Here are five stocks we like better.
- Strong AI-driven growth: Fiscal Q3 revenue rose 14% year over year to $22.4 million, while Thermal Processing
Akebia Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Akebia Therapeutics, Inc.? Here are five stocks we like better.
- Vafseo revenue rose sharply to $21.3 million in Q2 2026, up 34% sequentially and 60% year over year
EQS-Adhoc: Enapter AG: Vereinbarung mit Patrimonium zur Ablösung von Anleiheverbindlichkeiten in Höhe von rund EUR 26 Mio.; Neuausrichtung auf ein asset-light-Geschäftsmodell; geplante Kapitalmaßnahme
EQS-Adhoc: Enapter AG: Vereinbarung mit Patrimonium zur Ablösung von Anleiheverbindlichkeiten in Höhe von rund EUR 26 Mio.; Neuausrichtung auf ein asset-light-Geschäftsmodell; geplante Kapitalmaßnahme
Archrock Q2 Earnings Call Highlights
Key Points
- Interested in Archrock, Inc.? Here are five stocks we like better.
- Strong core performance: Archrock reported $67 million in net income, $213 million in adjusted EBITDA and $0.38 in
Amprius Technologies Q2 Earnings Call Highlights
Key Points
- Interested in Amprius Technologies, Inc.? Here are five stocks we like better.
- Record results and raised guidance: Amprius reported second-quarter revenue of $34 million, up 19%
LogicBio Therapeutics: ContextLogic Unveils $850M gChem Specialty Chemicals Acquisition
Key Points
- Interested in LogicBio Therapeutics, Inc.? Here are five stocks we like better.
- ContextLogic plans to acquire gChem for $850 million in cash, its second operating-business acquisition
XPEL Q2 Earnings Call Highlights
Key Points
- Interested in XPEL, Inc.? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 14.7% year over year to $143.1 million, while EBITDA increased 17.6% and adjusted
United Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in United Therapeutics Corporation? Here are five stocks we like better.
- Second-quarter revenue was approximately $783 million, essentially flat sequentially, as